ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Improving early phase oncology clinical trial design using Bayesian-based BOIN and BOP2 designs
Tim Clark, VP Drug Development Solutions, Martin Lachs, VP Project Management Oncology & Cell Therapeutics and Alan Phillips, Sr. Director Biostatistics, offer insights on selecting and implementing the appropriate model-based or model-assisted design for early phase oncology trials.
Evaluating similarities and differences between machine learning and traditional statistical modeling in healthcare analytics
ICON experts explain why data scientists and analysts should not necessarily have to choose between either machine learning or statistical modeling as a mutually exclusive decision tree.
The innovative 'digiverse' that's propelling transformative decentralised clinical trials
Dr. Isaac R. Rodriguez-Chavez offers his insights on the use of innovative digital health technologies and digital ecosystems to support decentralised clinical trials.
Steve Cutler features in Executive Insights in association with KPMG
This article features an interview with Steve Cutler after ICON won Company of the Year.
ICON reveals record €2.28bn business win in Q1
Steve Cutler is quoted in this article on the record earnings ICON achieved in the first quarter of 2022 despite the ongoing disruption from the war in Ukraine.
Ewa Kleczyk, Vice President, Advanced & Custom Analytics, offers her insights on the use of precision medicine in clinical trials.
How can real world data improve clinical trial outcomes?
Kathleen Mandziuk, VP of Project Management and Real-World Solutions, offers her insights on the use of real world data to improve clinical trials outcomes.
Injecting real-world data into every day clinical trials
Kathleen Mandziuk, VP Real World Solutions, offers insights into the importance of real-world data in clinical trials and how it can be used to inform trial recruitment.
The silent problem: Machine learning model failure - How to diagnose and fix ailing machine learning models
This article considers the current issues around the applicability of Machine Learning Models.
Welcome to the big leagues: How the US market is supercharging Irish businesses
Steve Cutler discusses how Irish companies, including ICON, intend to approach the US market, which brings a wealth of new opportunities and challenges.